Sponsor:
University of Southern California
Code:
NCT06422455
Conditions
Breast Carcinoma
Male Breast Carcinoma
Malignant Solid Neoplasm
Metastatic Prostate Carcinoma
Ovarian Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Best Practice
Educational Intervention
Electronic Health Record Review
Genetic Counseling
Interview
Brief summary:
Conditions
Breast Carcinoma
Male Breast Carcinoma
Malignant Solid Neoplasm
Metastatic Prostate Carcinoma
Ovarian Carcinoma
Study ID
NCT06422455
Start date
Oct 24, 2023
Status verified date
Mar, 2026
Completion date
Oct 24, 2028
Anticipated
Primary completion date
Oct 24, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
800 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Health Services Research
Arms
experimental: Intervention Phase Arm A (PERLA)
active comparator: Intervention Phase Arm B (usual care)
Interventions
Best Practice
Educational Intervention
Electronic Health Record Review
Genetic Counseling
Interview
Survey Administration
Primary outcome measure
Central contacts
Locations
USC / Norris Comprehensive Cancer Center
Recruiting
Los Angeles, California, United States, 90033
Contacts
Principal Investigator:
Charite Ricker
University of Rochester
Recruiting
Rochester, New York, United States, 14642
Contacts
Meghan L. Underhill
meghan_blazey@urmc.rochester.eduPrincipal Investigator:
Meghan L. Underhill
Sponsor
University of Southern California
Last update posted
Mar 18, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Southern California on 2026-03-18.